Neonatal Respiratory Distress Syndrome

Neonatal Respiratory Distress Syndrome (RDS), historically called Hyaline Membrane Disease (HMD), is the commonest cause of respiratory distress in the preterm newborn and results fundamentally from a deficiency of pulmonary surfactant. It is a self-limiting disease whose natural course is dramatically altered by antenatal corticosteroids, early CPAP, and exogenous surfactant — making it a recurring favourite across NEET PG sessions.

Definition & basic concept

RDS is a developmental deficiency of surfactant in the immature lung leading to progressive atelectasis, decreased lung compliance, ventilation–perfusion mismatch, and hypoxaemia that begins within minutes to hours of birth and typically peaks at 48–72 hours.

High-yield: Surfactant is produced by type II pneumocytes and is composed mainly of phospholipids (~80–90%) — the most important being dipalmitoyl phosphatidylcholine (DPPC / lecithin) — plus phosphatidylglycerol, neutral lipids, and surfactant proteins SP-A, SP-B, SP-C, SP-D. Its core function is to reduce alveolar surface tension and prevent end-expiratory collapse (Laplace's law: P = 2T/r).

Surfactant synthesis begins around 24–28 weeks but reaches functionally adequate levels only by ~34–36 weeks, which is why prematurity is the single most important determinant.

Epidemiology — incidence falls with gestation

Gestational age	Approximate incidence of RDS
< 28 weeks	~ 60–80%
28–34 weeks	~ 30–50%
34–36 weeks	~ 10–20%
> 37 weeks (term)	Rare (< 5%)

High-yield: RDS incidence and severity are inversely proportional to gestational age. The single strongest risk factor is prematurity.

Etiology & risk factors

Surfactant deficiency may be due to immaturity, impaired synthesis, or increased inactivation.

Factors that INCREASE risk (decrease surfactant):

• Prematurity (chief factor)
• Infant of a diabetic mother (IDM) — fetal hyperinsulinaemia antagonises cortisol-driven surfactant maturation, so RDS can occur even at term
• Caesarean section without labour — absence of the catecholamine/cortisol surge of labour
• Perinatal asphyxia, hypothermia, acidosis (inactivate surfactant)
• Male sex; second-born twin
• Maternal haemorrhage / hydrops; multiple gestation
• Genetic surfactant protein deficiencies (e.g. SP-B deficiency — fatal, autosomal recessive)

Factors that DECREASE risk (accelerate lung maturity):

• Antenatal corticosteroids
• Chronic intrauterine stress: pre-eclampsia/PIH, IUGR, prolonged rupture of membranes (PROM), maternal opioid use
• Maternal hypertension, sickle cell disease

High-yield: Chronic intrauterine stress (PIH, IUGR, prolonged PROM) accelerates lung maturation and protects against RDS, whereas IDM and elective LSCS without labour increase the risk.

Mnemonic for risk factors → "PROMISE-D": Prematurity, Respiratory distress in prior sibling, Operative delivery (LSCS no labour), Male/Multiple gestation, Infant of Diabetic mother, Second twin, Erythroblastosis/hydrops; Diabetes.

Pathophysiology — the vicious cycle

Surfactant deficiency raises alveolar surface tension → diffuse alveolar atelectasis → reduced functional residual capacity and decreased lung compliance ("stiff lungs") → increased work of breathing.

Stepwise cascade:

Surfactant deficiency → ↑ surface tension → alveolar collapse (atelectasis) → ↓ compliance + V/Q mismatch → hypoxaemia + hypercarbia + acidosis → pulmonary vasoconstriction → ↓ pulmonary blood flow → ischaemic injury to type II cells & endothelium → plasma leak of fibrin/protein into alveoli → eosinophilic "hyaline membranes" → further surfactant inactivation → worsening cycle.

The classic histological hallmark is the hyaline membrane — an eosinophilic, amorphous layer of fibrin and necrotic cellular debris lining the alveolar ducts and terminal bronchioles (hence "Hyaline Membrane Disease").

Hypoxia and acidosis may sustain a right-to-left shunt through the foramen ovale and a persistently patent ductus arteriosus (PDA), aggravating hypoxaemia.

Clinical features

Onset is within the first 4–6 hours of life (often immediately at birth in the very preterm), with progressive worsening over 48–72 hours.

Cardinal signs (the classic respiratory distress quartet plus more):

• Tachypnoea (respiratory rate > 60/min)
• Expiratory grunting (physiological auto-PEEP from partial glottic closure to maintain FRC)
• Intercostal, subcostal & suprasternal retractions
• Nasal flaring
• Cyanosis unrelieved by supplemental oxygen
• Decreased air entry; fine inspiratory crackles
• May progress to apnoea, shock, and respiratory failure

High-yield: Grunting is a compensatory mechanism — the baby exhales against a partly closed glottis to generate end-expiratory pressure and prevent alveolar collapse. It is an early and important sign of RDS.

The Silverman–Andersen score quantifies respiratory distress severity in newborns.

Silverman–Andersen retraction score

Parameter	0	1	2
Upper chest movement	Synchronised	Lag on inspiration	See-saw
Lower chest retraction	None	Just visible	Marked
Xiphoid retraction	None	Just visible	Marked
Nasal flaring	None	Minimal	Marked
Expiratory grunt	None	Audible by stethoscope	Audible by naked ear

High-yield: In the Silverman–Andersen score, a HIGHER score = WORSE distress (max 10). This is the opposite of the APGAR score, where a higher score is better. A score of 0 means no distress; >6 indicates impending respiratory failure.

Investigations

Chest radiograph — the classic image

The CXR in RDS shows:

• Diffuse, fine reticulogranular "ground-glass" appearance (uniform haziness)
• Air bronchograms (air-filled bronchi outlined against airless alveoli)
• Low lung volumes (hypoaeration — bell-shaped thorax)
• In severe disease, a "white-out" lung (complete opacification obscuring the cardiac border)

High-yield: The triad of ground-glass (reticulogranular) opacities + air bronchograms + low lung volumes is the textbook NEET PG radiographic signature of RDS. Low lung volume distinguishes it from most other causes of neonatal respiratory distress.

Tests of fetal lung maturity (antenatal, on amniotic fluid)

Test	Mature (low RDS risk) cut-off	Note
Lecithin : Sphingomyelin (L/S) ratio	≥ 2 : 1	Gold-standard classic test; < 2 suggests immaturity / RDS risk
Phosphatidylglycerol (PG)	Present	Appears ~ 35 weeks; most reliable in IDM where L/S can be falsely reassuring
Foam / Shake (bubble) stability test	Stable foam after shaking with ethanol	Bedside screening
Lamellar body count	Higher counts = mature	Rapid automated test
Surfactant : Albumin (TDx-FLM) ratio	≥ 55 mg/g

High-yield: L/S ratio ≥ 2:1 → lung maturity. In an infant of a diabetic mother the L/S ratio may be falsely "mature" (≥2) yet RDS still occurs because insulin blocks phosphatidylglycerol synthesis — so presence of PG is the more reliable marker in IDM.

Other investigations

• Arterial blood gas: hypoxaemia, hypercarbia, mixed/respiratory acidosis
• Blood glucose, calcium, electrolytes
• Sepsis screen + blood culture — Group B Streptococcal (GBS) pneumonia is clinically and radiologically indistinguishable from RDS; empirical antibiotics are started until sepsis excluded
• Echocardiography to assess PDA / pulmonary hypertension / structural disease

Management

The pillars are prevention (antenatal steroids), respiratory support (CPAP/ventilation), surfactant replacement, and supportive care.

1. Antenatal prevention — corticosteroids (most important preventive measure)

High-yield: A single course of antenatal corticosteroids is given to mothers at risk of preterm delivery between 24 and 34 weeks (extended up to ~36⁶/⁷ weeks in some guidelines). Regimen: Betamethasone 12 mg IM, 2 doses 24 h apart, OR Dexamethasone 6 mg IM every 12 h × 4 doses. Maximum benefit occurs if delivery is >24 hours and <7 days after the first dose. They act by inducing surfactant synthesis and accelerating lung structural maturity, and additionally reduce IVH, NEC, and mortality.

2. Delivery-room & general care

• Maintain thermoneutral environment (avoid hypothermia and acidosis, which inactivate surfactant)
• Gentle resuscitation; avoid excessive oxygen — titrate to SpO₂ ~90–95% to prevent hyperoxic injury (ROP, BPD)
• Maintain fluids, glucose, blood pressure, and acid–base balance

3. Respiratory support — CPAP first

High-yield: Early nasal CPAP (Continuous Positive Airway Pressure) is the first-line respiratory support in spontaneously breathing preterms with RDS. CPAP maintains FRC, splints open alveoli, and reduces the need for intubation and mechanical ventilation. Start at 5–6 cm H₂O.

If CPAP fails (rising FiO₂ requirement, apnoea, severe acidosis) → mechanical ventilation with gentle, lung-protective settings.

4. Surfactant replacement therapy

High-yield: Exogenous surfactant is given intratracheally. Natural (animal-derived) surfactants (e.g. Beractant/Survanta, Poractant alfa/Curosurf, Calfactant) are superior to older synthetic ones because they contain surfactant proteins SP-B and SP-C. Earlier "rescue" administration improves outcomes.

• Prophylactic surfactant: considered for extremely preterm (e.g. <26–28 weeks) not given antenatal steroids.
• Rescue / early selective: standard approach — given once RDS is established/intubated.
• LISA / MIST (Less Invasive / Minimally Invasive Surfactant Therapy via thin catheter while on CPAP) and INSURE (INtubate–SURfactant–Extubate to CPAP) reduce ventilator exposure.

5. Adjuncts

• Caffeine citrate for apnoea of prematurity and to facilitate extubation
• Treat haemodynamically significant PDA (fluid restriction, ibuprofen/indomethacin/paracetamol; surgical/device ligation if refractory)
• Empirical antibiotics until GBS sepsis excluded

Therapeutic flow: Antenatal steroids → delivery-room CPAP/PPV with blended O₂ → if persistent distress/↑FiO₂: surfactant (LISA/INSURE) → CPAP → mechanical ventilation if failing → wean with caffeine.

Complications

Acute:

• Pneumothorax / pulmonary interstitial emphysema (PIE) — air leaks, often ventilator-related
• PDA with left-to-right shunt → pulmonary oedema, CHF
• Pulmonary haemorrhage
• Intraventricular haemorrhage (IVH) — fluctuating cerebral perfusion
• Persistent pulmonary hypertension of the newborn (PPHN)

Chronic:

• Bronchopulmonary dysplasia (BPD) — defined by oxygen dependence at 36 weeks postmenstrual age (or for ≥28 days); due to oxygen toxicity + baro/volutrauma
• Retinopathy of prematurity (ROP) — from hyperoxia
• Necrotising enterocolitis (NEC)
• Neurodevelopmental impairment

High-yield: Oxygen toxicity is the common thread linking the two most-tested chronic complications — BPD (lungs) and ROP (eyes) — hence the emphasis on targeting modest SpO₂ (~90–95%), not 100%.

Key differential diagnoses

Condition	Onset / setting	CXR	Distinguishing clue
RDS (HMD)	Preterm; within hours, worsens 48–72 h	Ground-glass, air bronchograms, low volume	Surfactant deficiency; improves after surfactant
Transient Tachypnoea of Newborn (TTN)	Term/late preterm, LSCS; resolves in 24–72 h	Prominent vascular markings, fluid in fissure, hyperinflation	"Wet lung" — delayed clearance of fetal lung fluid; benign
Meconium Aspiration Syndrome (MAS)	Term/post-term, meconium-stained liquor	Patchy coarse infiltrates, hyperinflation, air leaks	Birth asphyxia, meconium staining; PPHN
Neonatal pneumonia (esp. GBS)	Any GA; PROM, maternal fever	Can mimic RDS exactly	Sepsis signs; positive cultures; cover empirically
Congenital diaphragmatic hernia	At birth	Bowel loops in thorax, mediastinal shift, scaphoid abdomen	Severe distress, absent breath sounds one side
Cyanotic congenital heart disease	Any GA	Often clear lungs / specific contours	Cyanosis not relieved by O₂ (failed hyperoxia test); no/minimal distress initially

High-yield: RDS = low lung volume; TTN = hyperinflation with fluid in horizontal fissure. TTN follows elective caesarean and self-resolves within 24–72 hours, whereas RDS worsens before improving (around day 3) and needs surfactant.

Recently asked / exam angle

• "Most common cause of respiratory distress in a preterm neonate" → RDS / Hyaline Membrane Disease (surfactant deficiency).
• CXR image-based question: ground-glass reticulogranular pattern + air bronchograms + low volumes → RDS.
• L/S ratio cut-off of 2:1 and the catch that IDM can have a falsely mature L/S ratio, with phosphatidylglycerol presence being the reliable maturity marker.
• Surfactant composition — most abundant phospholipid = dipalmitoyl phosphatidylcholine (lecithin); produced by type II pneumocytes.
• Antenatal steroid regimen and timing (betamethasone/dexamethasone, 24–34 weeks, optimal window 24 h–7 days).
• Silverman–Andersen score vs APGAR — higher Silverman score means worse distress (reverse of APGAR).
• Natural vs synthetic surfactant — natural surfactants (contain SP-B/SP-C) are preferred.
• CPAP as first-line support and the INSURE/LISA technique.
• Complications matched to oxygen toxicity — BPD (O₂ dependence at 36 weeks PMA) and ROP.
• Conditions that protect vs increase risk — PIH/IUGR/PROM protect; IDM and elective LSCS increase.

Rapid revision

1. RDS = surfactant deficiency in the preterm lung; aka Hyaline Membrane Disease.
2. Surfactant made by type II pneumocytes; chief phospholipid = dipalmitoyl phosphatidylcholine (lecithin); key proteins SP-B & SP-C.
3. Incidence is inversely proportional to gestational age; chief risk factor = prematurity.
4. IDM and elective LSCS without labour increase risk; PIH, IUGR, PROM and antenatal steroids decrease it.
5. Clinical: tachypnoea, grunting, retractions, nasal flaring, cyanosis within hours of birth, peaking at 48–72 h.
6. Silverman–Andersen score: higher = worse (opposite of APGAR).
7. CXR: ground-glass reticulogranular opacities + air bronchograms + low lung volumes, up to white-out.
8. Fetal lung maturity: L/S ratio ≥ 2:1 = mature; PG presence more reliable in IDM (falsely high L/S).
9. Prevention: antenatal betamethasone/dexamethasone at 24–34 weeks, best >24 h to <7 days before delivery.
10. Treatment: early CPAP first, intratracheal natural surfactant (INSURE/LISA), ventilation if failing, caffeine for apnoea.
11. Target SpO₂ ~90–95% to avoid oxygen toxicity → BPD (O₂ need at 36 weeks PMA) and ROP.
12. Closest mimics: GBS pneumonia (treat empirically) and TTN (hyperinflation, fluid in fissure, self-limited).